Pharma · Private company
Lupin, Inc.
Track this companyFree. Adds Lupin, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- LUBT010 (proposed ranibizumab biosimilar)Phase 3 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- Lucentis (ranibizumab)Phase 3 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- Lupin albuterol HFA MDIPhase 3 · Mild Persistent AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- methacholine chloridePhase 3 · Mild Persistent AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- ProAir HFAPhase 3 · Mild Persistent AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Reference Product (Spiriva®)Phase 3 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Test Product (tiotropium bromide inhalation powder)Phase 3 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMDPHASE3 · COMPLETED · started Sep 14, 2020ClinicalTrials.gov NCT04690556 · fetched Nov 12, 2026
- Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device RobustnessPHASE3 · COMPLETED · started Nov 21, 2017ClinicalTrials.gov NCT03137992 · fetched Nov 12, 2026
- Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild AsthmaPHASE3 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02584257 · fetched Nov 12, 2026